Credelio Cat is a drug owned by ELANCO US INC. It is protected by 1 US drug patent filed in 2030. All patents are active. Details of Credelio Cat’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
Exclusivity Information
Credelio Cat holds 1 exclusivity out of which 1 has expired. Details of Credelio Cat's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Dec 09, 2022 |
About Credelio Cat
Credelio Cat is a drug
owned by ELANCO US INC.
Credelio Cat uses
Lotilaner as the active
ingredient.
Active Ingredient:
Credelio Cat uses
Lotilaner as the active ingredient.
Check out other Drugs and Companies using
Lotilaner ingredient.